Table 4.
Micro- Dilution |
CTR (mg/mL) | TRF (mg/mL) | P407 (mg/mL) | F-UBO (mg/mL) | |
---|---|---|---|---|---|
30.230 ± 0.630 | 122.330 ± 0.850 | 10.050 ± 0.180 | 50.133 ± 1.305 | 63.533 ± 1.955 | |
1 | 1.511 ± 0.043 | 6.117 ± 0.042 | 0.500 ± 0.009 | 2.506 ± 0.065 | 3.176 ± 0.097 |
2 | 0.755 ± 0.022 | 4.893 ± 0.034 | 0.250 ± 0.004 | 1.253 ± 0.032 | 1.588 ± 0.048 |
3 | 0.377 ± 0.011 | 3.914 ± 0.027 | 0.125 ± 0.002 | 0.626 ± 0.016 | 0.794 ± 0.024 |
4 | 0.188 ± 0.005 | 3.131 ± 0.021 | 0.061 ± 0.001 | 0.315 ± 0.008 | 0.397 ± 0.012 |
5 | 0.094 ± 0.002 | 2.505 ± 0.017 | 0.031 ± 0.001 | 0.157 ± 0.004 | 0.199 ± 0.008 |
6 | 0.047 ± 0.002 | 2.004 ± 0.014 | 0.015 ± 0.001 | 0.078 ± 0.002 | 0.100 ± 0.004 |
7 | 0.023 ± 0.001 | 1.603 ± 0.011 | 0.007 ± 0.001 | 0.039 ± 0.001 | 0.049 ± 0.002 |
CTR—ceftriaxone; TRF—terbinafine; P407—poloxamer 407; F-UBO—bioadhesive oral films with U. barbata extract in canola oil.